AdaptHealth Corp. cash flow statement AHCO

In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, AdaptHealth Corp. generated $156.6 million of cash from operations, down 2.8% from the same quarter a year earlier. It spent $105.5 million on capital expenditures. That left free cash flow of $51.1 million.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 30, 2026
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Operating
Depreciation and amortization
441
+17.7%
117
+19.6%
120
+30.2%
106
+12.9%
98
+7.7%
98
+7.7%
92
+1.3%
94
+1.6%
91
-2.0%
Stock-based compensation
18
-12.4%
1
-78.1%
6
-9.4%
7
+23.3%
5
+20.4%
5
+515.4%
6
+17.5%
5
+16.8%
4
-17.7%
Operating cash flow
579
+1.7%
157
-2.8%
145
-10.3%
94
-1.9%
183
+21.8%
161
+11.5%
162
-18.2%
96
+94.8%
150
-3.1%
Investing
Capital expenditures
497
+39.6%
106
+12.0%
166
+87.5%
121
+26.8%
104
+34.3%
94
+58.2%
89
+9.1%
96
+8.8%
77
-12.8%
Investing cash flow
-639
-140.7%
-108
-15.9%
-203
-2210.7%
-204
-113.9%
-124
-43.3%
-93
-71.0%
10
+111.8%
-96
-8.8%
-87
+3.9%
Financing
Debt repaid
780
+183.6%
330
+560.1%
411
+174.0%
14
-43.7%
25
-50.0%
50
-78.1%
150
+25.0%
25
+0.0%
50
+150.0%
Stock buybacks
—
—
—
—
—
—
—
—
0
-100.0%
Financing cash flow
61
+118.8%
-12
+79.4%
53
+133.7%
53
+193.8%
-33
+39.0%
-57
+5.4%
-157
-23.9%
-56
-235.7%
-54
-23.1%
Change in cash
Net change in cash
0
+101.7%
37
+218.9%
-5
-131.2%
-58
-3.7%
26
+169.5%
12
-61.4%
15
+253.9%
-56
-2404.7%
10
-54.4%
Free cash flow
82
-61.6%
51
-23.6%
-21
-128.6%
-27
-47296.6%
79
+8.5%
67
-21.2%
73
-37.2%
-0
+99.9%
73
+9.7%
Per share
Free cash flow per share
0.61
-60.9%
0.37
-23.1%
-0.15
-128.8%
-0.20
-46954.5%
0.61
+13.9%
0.49
-21.6%
0.53
-37.6%
-0.00
+99.9%
0.54
+6.7%
Shareholder returns
Returned to shareholders
—
—
—
—
—
—
—
—
0
Share of free cash flow
—
—
—
—
—
—
—
—
0.00%
Ratios
Free cash flow margin
2.38%
6.85%
-2.83%
-3.35%
6.24%
9.94%
11.16%
-0.01%
8.53%
Capital expenditures to revenue
14.46%
14.15%
22.46%
14.79%
8.18%
14.02%
13.49%
12.29%
9.03%
Stock-based compensation to revenue
0.54%
0.16%
0.75%
0.80%
0.40%
0.79%
0.93%
0.68%
0.50%
Cash conversion
—
—
—
—
—
6.57x
11.04x
—
2.99x
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-Home Health Care Services (SIC 8082)
Listed as
AHCO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Conshohocken, PA
SEC filer status
Large accelerated filer
SEC CIK
1725255
Former names
DFB Healthcare Acquisitions Corp. (until Nov 8, 2019)

Other Services-Home Health Care Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.